Step Stone Group LP Novo Cure LTD Transaction History

Step Stone Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$61.86 - $97.8 $7.14 Million - $11.3 Million	-115,479 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$42.22 - $63.23 $4.22 Million - $6.32 Million	-100,000 Reduced 46.41%	115,479 $7.3 Million
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $6.39 Million - $11.2 Million	-200,000 Reduced 48.14%	215,479 $10.4 Million
Q3 2018 Nov 09, 2018	SELL	$32.0 - $52.4 $14.4 Million - $23.6 Million	-450,000 Reduced 51.99%	415,479 $21.8 Million
Q2 2018 Aug 13, 2018	SELL	$19.85 - $32.0 $9.93 Million - $16 Million	-500,000 Reduced 36.62%	865,479 $27.1 Million
Q1 2018 May 15, 2018	SELL	$19.3 - $23.65 $4.83 Million - $5.91 Million	-250,000 Reduced 15.48%	1,365,479 $29.8 Million
Q3 2017 Nov 09, 2017	BUY	$18.05 - $21.75 $29.2 Million - $35.1 Million	1,615,479	1,615,479 $32.1 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Step Stone Group LP, based on Form 13F filings with the SEC.

Stay updated on Step Stone Group LP with notifications on news.